Cargando…

Pneumocystis Pneumonia in a Non-Immunocompromised Lung Cancer Patient after Surgery: A Case Report

We present the Pneumocystis pneumonia case of a 64-year-old man with no remarkable history except for hypertension, who had not undergone any treatment other than surgery. On postoperative day 7, high-resolution computed tomography findings revealed multifocal ground-glass opacifications with interl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae-Woo, Lee, Jun-Ho, Lee, Hyo-Jin, Kim, So-Woon, Choi, Hye-Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601697/ https://www.ncbi.nlm.nih.gov/pubmed/36292509 http://dx.doi.org/10.3390/healthcare10102063

Ejemplares similares

Spatiotemporal Clusters and Trends of Pneumocystis Pneumonia in Korea
por: Kim, Hwa Sun, et al.
Publicado: (2022)

Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea
por: Kim, Tark, et al.
Publicado: (2015)

Is It Possible to Differentiate Pneumocystis jirovecii Pneumonia and Colonization in the Immunocompromised Patients with Pneumonia?
por: Aguilar, Yudy A., et al.
Publicado: (2021)

Multiple nodular lesions following Pneumocystis pneumonia in a non‐HIV immunocompromised patient
por: Asakura, Takanori, et al.
Publicado: (2016)

Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients
por: Mu, Xiang-Dong, et al.
Publicado: (2016)

Simultaneous bilateral pneumothorax in an immunocompromised HIV patient with Pneumocystis jirovecii pneumonia
por: Matesanz López, Cristina, et al.
Publicado: (2018)

Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
por: Xue, Ting, et al.
Publicado: (2023)

Clinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice
por: Lee, Hea Yon, et al.
Publicado: (2017)

Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia
por: LONG, YINGJIAO, et al.
Publicado: (2014)

Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2013)

Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients
por: Sarasombath, Patsharaporn T., et al.
Publicado: (2021)

Supplementary Role of Immunological Indicators in the Diagnosis and Prognosis of Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients
por: Cao, Yaoqian, et al.
Publicado: (2022)

Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer
por: Lee, Eun Hye, et al.
Publicado: (2019)

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
por: Rabacal, Whitney, et al.
Publicado: (2022)

Diagnosis of Pneumocystis jirovecii pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients
por: Wang, Dong, et al.
Publicado: (2017)

Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with Pneumocystis jirovecii Pneumonia
por: Zhang, Nan-Nan, et al.
Publicado: (2019)

Pneumocystis pneumonia in children – the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients
por: Zajac-Spychała, Olga, et al.
Publicado: (2015)

Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy
por: Kim, Tark, et al.
Publicado: (2012)

Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
por: Puing, Alfredo G., et al.
Publicado: (2021)

Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
por: Chaar-Hernandez, Aldair, et al.
Publicado: (2022)

Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing
por: Duan, Jiali, et al.
Publicado: (2022)

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients
por: Ibrahim, Atif, et al.
Publicado: (2023)

Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia
por: Kim, Taeeun, et al.
Publicado: (2017)

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study
por: Gaborit, Benjamin Jean, et al.
Publicado: (2019)

Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
por: Tang, Guoxing, et al.
Publicado: (2021)

Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
por: Wang, Dongsheng, et al.
Publicado: (2022)

A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient
por: Bezzina, Alastair David, et al.
Publicado: (2022)

Pneumocystis Pneumonia in HIV-Infected and Immunocompromised Non-HIV Infected Patients: A Retrospective Study of Two Centers in China
por: Guo, Fei, et al.
Publicado: (2014)

Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient
por: Bhat, Pavan, et al.
Publicado: (2020)

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
por: Maillet, M., et al.
Publicado: (2013)

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia
por: Kim, Se Jin, et al.
Publicado: (2015)

Validation of the Pneumocystis pneumonia score in haematology patients with acute respiratory failure
por: Ko, Ryoung-Eun, et al.
Publicado: (2020)

Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Comparative Evaluation Between the RealStar Pneumocystis jirovecii PCR Kit and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR Kit for Detecting P. jirovecii in Non-HIV Immunocompromised Patients
por: Huh, Hee Jae, et al.
Publicado: (2019)

Clinical and translational research in Pneumocystis and Pneumocystis pneumonia
por: Huang, L.
Publicado: (2011)

Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing
por: Huang, Liping, et al.
Publicado: (2023)

Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
por: Schmidt, Julius J., et al.
Publicado: (2018)

Integrated multi-omics analyses reveal the altered transcriptomic characteristics of pulmonary macrophages in immunocompromised hosts with Pneumocystis pneumonia
por: Wang, Yawen, et al.
Publicado: (2023)

Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer
por: TOGASHI, YOSUKE, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ff88pqiuaq2kc3tudcio4leij8